Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate-LDE in Coronary and Aortic Atherosclerosis
NCT04616872Phase 3Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in atherosclerosis, coronary artery disease (CAD), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Status: unknown.
02
Drugs
methotrexate
03
Conditions
atherosclerosiscoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04616872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04616872.